Lords Mark Industries Limited
Lords Mark Industries Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management guided on revenue, margins and order book.
What the Q1 FY27 call signalled
5 of 5 strong
The short version
FY27 revenue projected at around ₹1,550 crores with ~20.8% EBITDA margin and ~12.8% PAT margin. FY27 revenue expected around ₹1,550 crores with EBITDA margin ~21% and PAT margin ~13.25%.
From Lords Mark Industries Limited's Q1 FY27 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- FY27 revenue projected at around ₹1,550 crores with ~20.8% EBITDA margin and ~12.8% PAT margin.
- FY28 expected consolidated revenue to cross ₹2,100 crores, representing over 25% growth from FY27.
- EBITDA margin for FY28 expected to expand to around 23-24%.
- Dialysis machine production capacity to increase from ~60 machines/month currently to 150 machines/month by end of next year.
- Commercial adoption of dialysis machines growing with confirmed order book of 500+ machines.
- Sickle cell testing expected to contribute significantly to FY28 revenues post-approval and tender.
- New medtech products at commercialization stage anticipated to add revenue from Q4 FY27 onwards.
2 more points management made on revenue & sales performance
Profitability & Margins
See what Lords Mark Industries Limited said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- The company plans a capex of around ₹300-350 crores over the next 2-3 years.
- Investment includes setting up a new manufacturing plant for dialysis machines and other upcoming MedTech products.
- A 2-acre site in Lucknow has been acquired to establish India’s/Asia’s largest IVD and biochemistry analyzer manufacturing facility.
- The dialysis manufacturing is currently partly outsourced; the new plant aims to bring production in-house to reduce dependency on OEMs.
- R&D investments target oncology, TB detection, dialysis, genomics, sickle cell screening, and AI integration across devices.
- Strategic focus on partnerships, global expansion (subsidiaries in the UK, Switzerland), and pipeline approvals.
2 more points management made on capital expenditure plans
Top-ranked in Commercial Services & Supplies
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Lords Mark Industries Limited said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Current confirmed order book for dialysis machines is around 500 units for the financial year.
- Additional discussions and negotiations are ongoing with various buyers and potential franchise partners for dialysis centers.
- Manufacturing capacity is about 60 machines per month currently, expected to scale up to 150 machines per month by end of next year.
- Delivery for 500-600 machines would take approximately 8 to 9 months, with phased, staggered deliveries as per client requirements.
- The pipeline of orders for dialysis machines exceeds 500 units, with 500 confirmed.
2 more points management made on order book & pipeline
Continue your research
What Lords Mark Industries's management said in earlier quarters
Others in Commercial Services & Supplies this season
- IIRM Holdings India Ltd (Q1 FY27)
Revenue from operations for Q1 FY27: ₹735.0 million, up 8.1% YoY (Page 9) . Key concall takeaways from IIRM Holdings India Ltd's Q1 FY27 earnings call — and…
- NDR INVIT Trust (Q1 FY27)
Year-on-year revenue growth: ~22% (calculated from INR 1,240.21 mn vs INR 1,015.59 mn) (Pages 12 and 14) . Key concall takeaways from NDR INVIT Trust's Q1 FY27…
- Indiabulls Limited (Q1 FY27)
Q1FY27 Revenue: ₹384.4 Cr (Page 5) . Key concall takeaways from Indiabulls Limited's Q1 FY27 earnings call — and how it ranks against sector peers.
- Creative Newtech Ltd (Q1 FY27)
Consolidated Revenue from Operations for Q1 FY27: ₹476.07 crore, up from ₹392.96 crore in Q1 FY26 (YoY growth approximately 21.12%). Key concall takeaways from…
Frequently Asked Questions
What were Lords Mark Industries Limited Q1 FY27 results?
FY27 revenue projected at around ₹1,550 crores with ~20.8% EBITDA margin and ~12.8% PAT margin. FY27 revenue expected around ₹1,550 crores with EBITDA margin ~21% and PAT margin ~13.25%.
What is Lords Mark Industries Limited share price analysis?
Lords Mark Industries Limited currently shows a moderate growth signal based on ranking data. The stock trades at a P/E of 44.7 with a market cap of ₹3,797 Cr. Investors should review the full earnings analysis for detailed insights.
Is Lords Mark Industries Limited planning capital expenditure?
The company plans a capex of around ₹300-350 crores over the next 2-3 years.
Keep Lords Mark Industries Limited on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.